Corporate Strategy & M&APfizer Bets Big on Obesity: GLP-1 Market Entry Planned by 2028 After Metsera DealViaNews Editorial Team (Finance)•Feb 18, 2026
Corporate M&ABig Pharma Bets Big on Oncology: M&A Wave and Regulatory Wins Reshape Cancer Drug MarketViaNews Editorial Team (Finance)•Feb 17, 2026